The relationship between RGS5 expression and cancer differentiation and metastasis in non-small cell lung cancer

Journal of Surgical Oncology

Volumn 105, Issue 4, 2012, Pages 420-424

  Huang, Guichun ^a   Song, Haizhu ^a   Wang, Rui ^a   Han, Xiaodong ^a   Chen, Longbang ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

non small cell lung carcinoma; regulator of G protein signaling 5; tumor metastasis; tumor vasculature

Indexed keywords

PROTEIN; REGULATOR OF G PROTEIN SIGNALLING PROTEIN 5; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84857036738     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22033     Document Type: Article

References (28)

1. Soltermann A, Tischler V, Arbogast S, et al.: Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 2008; 14: 7430-7437.
2. Martins SJ, Takagaki TY, Silva AG, et al.: Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma. Lung Cancer 2009; 64: 105-109.
3. Zhou J, Moroi K, Nishiyama M, et al.: Characterization of RGS5 in regulation of G protein-coupled receptor signaling. Life Sci 2001; 68: 1457-1469. (Pubitemid 32168073)
4. Druey KM, Ugur O, Caron JM, et al.: Amino-terminal cysteine residues of RGS16 are required for palmitoylation and modulation of Gi- and Gq-mediated signaling. J Biol Chem 1999; 274: 18836-18842.
5. Hendriks-Balk MC, Peters SL, Michel MC, et al.: Regulation of G protein-coupled receptor signalling: Focus on the cardiovascular system and regulator of G protein signalling proteins. Eur J Pharmacol 2008; 585: 278-291.
6. Willars GB,: Mammalian RGS proteins: Multifunctional regulators of cellular signalling. Semin Cell Dev Biol 2006; 17: 363-376. (Pubitemid 44066847)
7. Cho H, Kozasa T, Bondjers C, et al.: Pericyte-specific expression of Rgs5: Implications for PDGF and EDG receptor signaling during vascular maturation. FASEB J 2003; 17: 440-442.
8. Manzur M, Ganss R,: Regulator of g protein signaling 5: A new player in vascular remodeling. Trends Cardiovasc Med 2009; 19: 26-30.
9. Hamzah J, Jugold M, Kiessling F, et al.: Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 2008; 453: 410-414. (Pubitemid 351693122)
10. Boss CN, Grünebach F, Brauer K, et al.: Identification and characterization of T-cell epitopes deduced from RGS5, a novel broadly expressed tumor antigen. Clin Cancer Res 2007; 13: 3347-3355. (Pubitemid 46944922)
11. Yao M, Huang Y, Shioi K, et al.: A three-gene expression signature model to predict clinical outcome of clear cell renal carcinoma. Int J Cancer 2008; 123: 1126-1132.
12. Wang JH, Huang WS, Hu CR, et al.: Relationship between RGS5 expression and differentiation and angiogenesis of gastric carcinoma. World J Gastroenterol 2010; 16 (44): 5642-5646.
13. Brambilla E, Travis WD, Colby TV, et al.: The new World Health Organization classification of lung tumours. Eur Respir J 2001; 18: 1059-1068. (Pubitemid 34092881)
14. Tong X, Li K, Luo Z, et al.: Decreased TIP30 expression promotes tumor metastasis in lung cancer. Am J Pathol 2009; 174: 1931-1939.
15. Hamburger AW, Salmon SE,: Primary bioassay of human tumor stem cells. Science 1977; 197: 461-463.
16. Furuya M, Nishiyama M, Kimura S, et al.: Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma. J Pathol 2004; 203: 551-558. (Pubitemid 38529035)
17. Chen X, Higgins J, Cheung ST, et al.: Novel endothelial cell markers in hepatocellular carcinoma. Mod Pathol 2004; 17: 1198-1210. (Pubitemid 39312946)
18. Anger T, Klintworth N, Stumpf C, et al.: RGS protein specificity towards Gq- and Gi/o-mediated ERK 1/2 and Akt activation, in vitro. J Biochem Mol Biol 2007; 40: 899-910. (Pubitemid 350242275)
19. Anger T, Grebe N, Osinski D, et al.: Role of endogenous RGS proteins on endothelial ERK 1/2 activation. Exp Mol Pathol 2008; 85: 165-173.
20. Peinado H, Quintanilla M, Cano A,: Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: Mechanisms for epithelial mesenchymal transitions. J Biol Chem 2003; 278: 21113-21123. (Pubitemid 36806424)
21. Kurrey NK, K A, Bapat SA,: Snail and slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol Oncol 2005; 97: 155-165. (Pubitemid 40403688)
22. Friedl P, Wolf K,: Tumour-cell invasion and migration: Diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 362-374. (Pubitemid 37328856)
23. Bergers G, Song S,: The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005; 7: 452-464. (Pubitemid 41555617)
24. Berger M, Bergers G, Arnold B, et al.: Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood 2005; 105: 1094-1101. (Pubitemid 40170880)
25. Manzur M, Hamzah J, Ganss R,: Modulation of the "blood-tumor" barrier improves immunotherapy. Cell Cycle 2008; 7: 2452-2455.
26. Huang G, Chen L,: Tumor vasculature and microenvironment normalization: A possible mechanism of antiangiogenesis therapy. Cancer Biother Radiopharm 2008; 23: 661-667.
27. Lohela M, Bry M, Tammela T, et al.: VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 2009; 21: 154-165.
28. Cho H, Park C, Hwang IY, et al.: Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol 2008; 28: 2590-2597. (Pubitemid 351542360)